For the Attention of Community Pharmacies Currently Providing the Opioid Substitution Treatment (OST) Service
Dear Colleague
SPPG issued correspondence on 10 April 2025 regarding the community pharmacy OST service. Note: The link for return of OST contracts will now remain open until 9 May 2025.
SUMMARY
A new contract for the community pharmacy OST service is being implemented from April 2025.
The contract will further enhance governance arrangements for the delivery of the OST service and ensure timely payment of the retainer fee.
Pharmacies that currently dispense OST prescriptions are asked to submit a new contract using the MS forms link.
Note: The link for return of OST contracts will now remain open until 9 May 2025.
Service documentation including the new service specification and relevant resources are available on the BSO website here.
Pharmacy staff involved in the provision of the OST service are asked to ensure they are familiar with the necessary resources in line with the service specification and contract.
The NICPLD live webinar ‘Opioid Substitution Therapy‘ is scheduled for 21 May 2025, and will be recorded for those unable to attend.
ACTION
Contractors are asked to:
Review the correspondence issued by SPPG on 10 April 2025 and share with all relevant team members.
Complete a new contract for the OST service by 9 May 2025.
Please note: Those pharmacies who have already completed a new OST service contract recently do not need to resubmit.
Please contact Michael McCabe (michael.mccabe@hscni.net), Pharmacy Adviser if you have any further queries.
Further to the CPNI update on Experiential Learning (EL) which issued on 14 March 2025, contractors are reminded that there is still time to complete the CPNI EL survey. The survey has been extended and will now close on 30 April 2025.
SUMMARY
The CPNI EL survey provides contractors with an opportunity to give their views on what is working well with EL in community pharmacy, and what improvements may be helpful.
NICPLD has indicated that EL feedback will be used to inform a review of the programme and the development of an ongoing EL strategy.
EL queries can be sent to the NICPLD programme lead Helen Hirst by emailing h.hirst@qub.ac.uk. Alternatively, should you wish to speak to a member of the CPNI team please feel free to email Ennis.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for April 2025:
Drug
Pack Size
Concessionary Price
Alfuzosin 2.5mg tablets
60
£4.30
Amiodarone 200mg tablets
28
£1.99
Buprenorphine 8mg sublingual tablets sugar free
7
£9.25
Carbimazole 20mg tablets
100
£2.65
Carbimazole 5mg tablets
100
£4.63
Codeine 15mg/5ml linctus
200
£15.68
Codeine 15mg/5ml linctus sugar free
200
£12.58
Cyclizine 50mg/1ml solution for injection ampoules
Correspondence has been issued by SPPG on 28 April 2025 advising that the Living Well ‘Look after your mental health’ survey will now remain open until 6pm Wednesday 30th April 2025.
Contractors who have yet to complete this survey are asked to do so before the deadline.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.